Sector

Data & AI skills for life sciences and pharma

Two organisations in one: a regulated, validated side and a commercial side that moves at market speed.

A scientist working with a pipette in a laboratory

The challenge

Life sciences is really two organisations sharing a logo. On one side R&D, clinical and quality work in validated, auditable environments where every step has to be defensible years later. On the other, commercial, market access and supply chain teams move at ordinary business speed. A single generic data course speaks to neither.

The regulated side has a particular problem with AI. Nothing is impossible, but everything has to be explainable, reproducible and documented, and the burden of proof sits with you. That makes people cautious in a way that is entirely rational, and it means an AI programme that skips governance will simply be ignored by the people who most need it.

The commercial side has the opposite issue: plenty of data, plenty of tooling, and decisions made on analyses nobody in the room can fully interrogate. Market access, field force effectiveness and forecasting all reward someone who can ask the second question.

Use cases

  • Clinical and trial data. Reading and questioning an analysis without needing to run it yourself.
  • Regulatory and quality. Understanding what makes an AI-supported step defensible in a validated environment.
  • Pharmacovigilance and safety signals. Working with detection models while knowing what they miss.
  • Commercial and market access analytics. Judging what a territory or channel analysis really shows.
  • Supply chain and serialisation. Planning against forecasts you understand well enough to challenge.
  • AI assistants with confidential and patient data. Clear limits, understood by everyone, not just by legal.

What we deliver

Two behaviours, one per side of the house. On the regulated side: someone who can use AI support in a validated process and explain afterwards why it holds up — reproducible, documented, defensible years later. On the commercial side: someone who asks the second question about an analysis instead of taking the headline.

Both need knowledge before skill, because caution here is rational and a programme that ignores it gets ignored back. Then skill in your own tools, practised in the browser on your own cases, with a sandbox on your own subdomain where data cannot leave the building. Separate tracks for the two sides, so neither sits through material aimed at the other.

What makes it stick is ownership. Champions in both R&D and commercial, live sessions, and a handover to your own L&D at the end. Growth is measured from a baseline before the start and benchmarked against other organisations — evidence that survives a quality review rather than a satisfaction score.

Proof

Across all our clients, cohorts finish at 79% completion over the last twelve months and more than 10,000 learners, against an industry standard of roughly 12%.

We also work with Deeploy on AI governance and with Ortecha, whose work is aimed squarely at complex and regulated industries.

Roles in scope

Medical Affairs, Clinical Data Manager, Regulatory Affairs, Quality Manager, Market Access Manager, Commercial Analytics, Supply Chain Planner

Versus the industry

Around six times the industry standard, which sits at roughly 12% completion.

How it runs

Cohort-based, on your own data and tools, with skill growth measured before and after.

Book a discovery call

Our impact in numbers

Course completion

79%

over the last twelve months

Learners

10,000+

have been through our programmes

Average course rating

4.1/5

from 3,327 learner ratings

Who we train in this sector

Sector tells you what the proof looks like. Persona tells you what each group actually learns.

Your sector, your cases

Talk to us about your sector

Book a discovery call